Pure Global

SIEMENS HEALTHCARE S.A.S. - Authorized Company ProfileSIEMENS HEALTHCARE S.A.S.

Explore comprehensive authorized company profile for SIEMENS HEALTHCARE S.A.S. through Pure Global AI's free Colombia medical device database. This company manufactures 69 medical devices registered with INVIMA across 5 risk classes. Their registration history spans from Apr 04, 2023 to May 31, 2033.

This page provides detailed insights including recent registrations, risk class distribution (II: 47, I: 6, III: 5, and more), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.

Free Authorized Company Profile
Powered by Pure Global AI
69 Devices
5 Risk Classes
SIEMENS HEALTHCARE S.A.S.
SIEMENS HEALTHCARE S.A.S.
Authorized Company
69
Total Devices
5
Risk Classes
2023
Earliest
2033
Latest
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Recent Registrations
Latest 20 INVIMA device registrations

FTD VIRAL MENINGITIS

FTD VIRAL MENINGITIS

2873b23355973fa782c693ed7db9de25

III

URINALYSIS CONTROLS CHEK-STIX LIQUID QC KIT

URINALYSIS CONTROLS CHEK-STIX LIQUID QC KIT

ee77e0fe0b895f9734717d904f051855

II
May 31, 2033

ATELLICA CH ANTI-STREPTOLYSIN-O_3 (ASO_3)

ATELLICA CH ANTI-STREPTOLYSIN-O_3 (ASO_3)

49e609314bf9c4a7b86b0299e7f13042

II
Feb 13, 2033

ATELLICA CH LACTATE 2 (LAC 2)

ATELLICA CH LACTATE 2 (LAC 2)

d440d74c3a27076b77a2617ff3d3a13d

II
Dec 05, 2032

EQUIPO DE RAYOS X PARA CIRUGIA ARCO EN C SIEMENS

X-RAY EQUIPMENT FOR ARC SURGERY AT C SIEMENS

80afb0f69ff06c47a08aabd65563cd1c

IIb
Nov 13, 2029

EQUIPO HIBRIDO SPECT-CT SYMBIA/ SPECT CT

EQUIPO HIBRIDO SPECT-CT SYMBIA/ SPECT CT

d09cad5a1cf2807b079f24b41220cde2

IIb
Jul 30, 2029

SISTEMA DE RADIOGRAFIA SIEMENS / SISTEMA DE RADIOGRAFIA

SIEMENS RADIOGRAPHY SYSTEM / RADIOGRAPHY SYSTEM

487a3307faed063db1f047df970f6c2d

IIb
Jul 16, 2029

SISTEMA DE MAMOGRAFIA SIEMENS - SISTEMA DE MAMOGRAFรA

SIEMENS MAMMOGRAPHY SYSTEM - MAMMOGRAPHY SYSTEM

556cd1a45d9755e187aaa448f202b399

IIb
Jul 09, 2029

SISTEMA DE UROLOGIA SIEMENS /SISTEMA DE UROLOGIA

SIEMENS UROLOGY SYSTEM / UROLOGY SYSTEM

e444df735e27b799c94bd77c2b2eb40a

IIb
Jul 09, 2029

RUBELLA IGM

RUBELLA IGM

2cf2f901f2838bbdb524ee47de6cc0c4

III
Mar 27, 2029

EQUIPO HรBRIDO BIOGRAPH PET-CT COMPUESTO POR TOMร“GRAFO POR EMISIร“N DE POSITRONES PET Y UN TOMร“GRAFO COMPUTARIZADO CT SIEMENS / PET CT

BIOGRAPH PET-CT HYBRID EQUIPMENT COMPOSED OF POSITRON EMISSION TOMOGRAPH PET AND A CT SIEMENS / PET CT COMPUTED TOMOGRAPH

ccc669a696990a23f870d5e49ab373a5

IIb
Dec 26, 2028

ATELLICA IM SYPHILIS QUALITY CONTROL (SYPH QC)

ATELLICA IM SYPHILIS QUALITY CONTROL (SYPH QC)

d412484fd1a24bac2e5bc0e8b03e52ab

III
Sep 19, 2028

ATELLICA IM HEPATITIS A IGM QUALITY CONTROL (AHAVM QC)

ATELLICA IM HEPATITIS A IGM QUALITY CONTROL (AHAVM QC)

2675d0914206d85369dc30227d2764c1

III
Sep 14, 2028

SISTEMA PARA ANGIOGRAFIA AXIOM ARTIS SIEMENS / SISTEMA PARA ANGIOGRAFIA

ARTIS SIEMENS AXIOM ANGIOGRAPHY SYSTEM / ANGIOGRAPHY SYSTEM

52da6b2a8d3df086eda2216d0a4681ca

IIb
Jul 18, 2028

ATELLICA IM B-TYPE NATRIURETIC PEPTIDE (BNP)

ATELLICA IM B-TYPE NATRIURETIC PEPTIDE (BNP)

c57b4ffa22d4d7587df03c945bc0d0c0

II
Mar 09, 2028

ATELLICA IM HOMOCYSTEINE CALIBRATOR (HCY CAL)

ATELLICA IM HOMOCYSTEINE CALIBRATOR (HCY CAL)

0a0a881b4743872f154d2c0b06a584c9

II
Mar 09, 2028

ATELLICA CH CHOLINESTERASE (CHE)

ATELLICA CH CHOLINESTERASE (CHE)

e7412c6254b63838b193da4ba2a47543

II
Mar 09, 2028

ATELLICA CH GAMMA-GLUTAMYL TRANSFERASE (GGT)

ATELLICA CH GAMMA-GLUTAMYL TRANSFERASE (GGT)

35cb23ce5f95db32a8a608cd8dc73cbf

II
Mar 09, 2028

ATELLICA CH LACTATE DEHYDROGENASE L-P (LDLP)

ATELLICA CH LACTATE DEHYDROGENASE L-P (LDLP)

8a745598286418d990bbc26918c2ba94

II
Mar 09, 2028

ATELLICA CH UREA NITROGEN (UN_C)

ATELLICA CH UREA NITROGEN (UN_C)

cb770ed6900612527701264f0e9f4db1

II
Mar 09, 2028
Risk Class Distribution
Devices by risk class
II
47
68.1% of total
IIb
7
10.1% of total
I
6
8.7% of total
III
5
7.2% of total
IIa
4
5.8% of total